Profile
David A. Zarling is the founder of Colby Pharmaceutical Co. Prior to that, he worked as the President & Chief Executive Officer of Pangene Corp.
and as a Program Director at SRI International.
He also served as an Adjunct Associate Professor at The University of California, San Francisco.
Zarling received his undergraduate and graduate degrees from Dartmouth College and an MBA from Pepperdine University.
He also holds a doctorate from Baylor College of Medicine.
David A. Zarling active positions
| Companies | Position | Start |
|---|---|---|
Colby Pharmaceutical Co.
Colby Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for treating prostate and other hypoxic solid tumors | Chief Executive Officer | 2003-12-31 |
Former positions of David A. Zarling
| Companies | Position | End |
|---|---|---|
SRI International
SRI International Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit scientific research institute and organization | Corporate Officer/Principal | - |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Pangene Corp.
Pangene Corp. Pharmaceuticals: MajorHealth Technology Develops oncology drugs based on its DNA repair and recombination platform | President | - |
Training of David A. Zarling
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
SRI International
SRI International Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit scientific research institute and organization | Commercial Services |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pangene Corp.
Pangene Corp. Pharmaceuticals: MajorHealth Technology Develops oncology drugs based on its DNA repair and recombination platform | Health Technology |
Pepperdine University
Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colby Pharmaceutical Co.
Colby Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for treating prostate and other hypoxic solid tumors | Health Technology |
- Stock Market
- Insiders
- David A. Zarling
















